It has been reported that tumor-infiltrating lymphocytes (TILs) are more frequently observed in TN or HER2-positive breast cancer [50], and higher levels in tumor stroma are associated with higher rate of pCR [51] and better prognosis [52]. This evidence concerns the gene ERBB2 and neoplasm.